GSK's unusual Jemperli expansion plan wins FDA panel backing
IPO doors creak open as Mineralys seeks $192M
Trials cue up new use for Roche's eye disease drug Vabysmo
AstraZeneca CEO Pascal Soriot aims for 15 new drug launches by 2030
*please scroll down for all the latest news*
